Dexchlorpheniramine Maleate

6 trials 4 recruiting RRespiratory

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

4 Recruiting

1 Completed trials

6 Sponsors

13 Countries

Phase III

Phase II

Phase III: 3 Phase II: 3

Oversight events:

4 temporary halts 1 urgent safety measure across 2 trials

View oversight register →

Indications tested

Epidermolysis bullosa 1 Follicular lymphoma 1

Sponsors using this IMP

Fundacio Sant Joan De Deu 1 Hopital Fondation Adolphe De Rothschild 1 LYSARC 1 Medica Scientia Innovation Research S.L. 1 Rheacell GmbH & Co. KG 1 Unicancer 1

All trials

6 total

A phase 2 study to research the safety and efficacy of datopotamab deruxtecan for non-squamous non-small cell lung cancer patients with acti… Not authorised

2024-512369-14-00 Phase II 2 countries Medica Scientia Innovation Research S.L.
Phase III clinical trial of ABCB5+ MSCs for the treatment of EB Recruiting

2022-500266-10-00 Phase III 12 countries Rheacell GmbH & Co. KG
Immediate corticosteroid therapy and rituximab to prevent generalization in ocular myasthenia gravis: a PROBE-type multicenter, open-label, … Recruiting

2023-506656-24-00 Phase III 1 country Hopital Fondation Adolphe De Rothschild
MorningLyte: Evaluation of the benefits of the combination of mosunetuzumab plus lenalidomide versus a treatment with anti-CD20 monoclonal a… Recruiting

2023-505436-35-00 Phase III 6 countries Lysarc
Evaluation of Lymphadenectomy and Chemotherapy TIP (paclitaxel, ifosfamide and cisplatin) on Inguinal Lymph Nodes in Squamous Cell Carcinoma… Recruiting

2024-512827-36-00 Phase II 1 country Unicancer
Phase 2 study of the infusion of differentiated autologous T-cells from peripheral blood, expanded and transduced with a lentivirus to expre… Ended

2024-515467-66-00 Phase II 1 country Fundacio Sant Joan De Deu

Showing 1–6 of 6 trials

← All drugs A–Z